
Relation Therapeutics
Initial Transaction Details
Transaction Date
March 2024
Purpose of Financing
Venture
Stage of Company
Early Stage
Structure of Financing
Equity
Relation is a biotechnology company discovering and developing transformational medicines, with experimental and computational systems at its core. The company’s Lab-in-the-Loop approach combines single cell multi-omics directly from patient tissue, functional assays and machine learning to understand the biological processes in human health and disease. The company is rapidly advancing programmes using insights from its technology and data, starting with bone-related diseases.
Website